Gout and Kidney Disease

From a western standpoint, gout and CKD form a reinforcing loop. As GFR falls, renal urate clearance declines and hyperuricemia ensues, predisposing to crystal formation and gout flares. Epidemiologic data consistently show greater gout prevalence in CKD and higher CKD incidence among patients with gout; however, randomized trials indicate that pharmacologically lowering urate in patients without gout indications does not slow CKD progression. Thus, guidelines counsel using urate-lowering therapy primarily to meet gout-specific goals (target serum urate to prevent flares/tophi, prevent uric acid stones), not as a kidney-protection strategy. Management of flares shifts in CKD: NSAIDs are minimized or avoided due to nephrotoxicity; instead, low-dose colchicine (with renal dosing), systemic or intra-articular glucocorticoids, or IL‑1 inhibitors are used. For chronic control, allopurinol remains first-line even in CKD if initiated at low dose and titrated to urate targets; febuxostat is effective but carries cardiovascular safety caveats. Kidney-directed therapy complements gout care: SGLT2 inhibitors slow CKD progression and lower urate, and losartan provides uricosuric blood pressure control when appropriate. Lifestyle measures—DASH-style eating with reduced sodium, weight reduction, limiting beer/spirits and fructose-sweetened beverages, increasing low-fat dairy, and maintaining hydration—benefit both conditions. In uric acid stone formers, urine alkalinization and hydration reduce stone recurrence and protect kidney function. Routine screening for albuminuria/eGFR in gout and for hyperuricemia/gout in CKD enables proactive, integrated care.

In TCM, gout is often classified as damp-heat Bi obstructing the channels and joints, arising from spleen dysfunction in fluid transformation with secondary phlegm and stasis; recurrent flares may reflect underlying kidney deficiency failing to govern water and marrow. CKD represents a chronic depletion of kidney essence/Qi with lingering dampness and blood stasis in the kidneys’ network vessels. This shared terrain suggests a combined strategy: clear damp-heat during acute arthritic episodes (e.g., Simiao San/Er Miao San modifications) to relieve swelling and pain, move blood and resolve stasis to protect channels and collaterals, and tonify kidney and spleen in remission to sustain fluid metabolism and prevent recurrence. Diet and lifestyle are foundational—light, warm, low-grease meals; avoidance of alcohol and excessive sweets (which generate damp-heat); steady weight reduction; adequate rest and stress regulation. Acupuncture can provide analgesia and anti-inflammatory modulation during flares and support sleep and mood in chronic disease. Because CKD alters drug handling, herbal prescriptions must be individualized, started at conservative doses, and monitored for renal function and electrolytes; known nephrotoxic substances (e.g., aristolochic acid–containing herbs) should be strictly avoided. Evidence for TCM approaches is growing but remains limited by small trials and heterogeneity; they are best used as adjuncts to biomedical care, coordinated among qualified practitioners to ensure safety and integration with urate-lowering and kidney-protective therapies.